SG11202010583VA - Polymorphic and amorphous forms of isoquinolinone and methods of use thereof - Google Patents
Polymorphic and amorphous forms of isoquinolinone and methods of use thereofInfo
- Publication number
- SG11202010583VA SG11202010583VA SG11202010583VA SG11202010583VA SG11202010583VA SG 11202010583V A SG11202010583V A SG 11202010583VA SG 11202010583V A SG11202010583V A SG 11202010583VA SG 11202010583V A SG11202010583V A SG 11202010583VA SG 11202010583V A SG11202010583V A SG 11202010583VA
- Authority
- SG
- Singapore
- Prior art keywords
- isoquinolinone
- polymorphic
- methods
- amorphous forms
- amorphous
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862664020P | 2018-04-27 | 2018-04-27 | |
| PCT/US2019/029751 WO2019210327A1 (en) | 2018-04-27 | 2019-04-29 | Polymorphic and amorphous forms of isoquinolinone and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202010583VA true SG11202010583VA (en) | 2020-11-27 |
Family
ID=68295819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202010583VA SG11202010583VA (en) | 2018-04-27 | 2019-04-29 | Polymorphic and amorphous forms of isoquinolinone and methods of use thereof |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210371385A1 (ja) |
| EP (1) | EP3784244A1 (ja) |
| JP (1) | JP2021522341A (ja) |
| KR (1) | KR20210015795A (ja) |
| CN (1) | CN112384221A (ja) |
| AU (1) | AU2019260835A1 (ja) |
| BR (1) | BR112020021977A2 (ja) |
| CA (1) | CA3098603A1 (ja) |
| MX (1) | MX2020011376A (ja) |
| SG (1) | SG11202010583VA (ja) |
| WO (1) | WO2019210327A1 (ja) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8242134B2 (en) * | 2008-09-15 | 2012-08-14 | H. Lundbeck A/S | Isoquinolinone derivatives as NK3 antagonists |
| MY164998A (en) * | 2008-09-15 | 2018-02-28 | Sojournix Inc | Isoquinolinone derivatives as nk3 antagonists |
-
2019
- 2019-04-29 CN CN201980038766.XA patent/CN112384221A/zh active Pending
- 2019-04-29 MX MX2020011376A patent/MX2020011376A/es unknown
- 2019-04-29 US US17/050,807 patent/US20210371385A1/en not_active Abandoned
- 2019-04-29 WO PCT/US2019/029751 patent/WO2019210327A1/en unknown
- 2019-04-29 SG SG11202010583VA patent/SG11202010583VA/en unknown
- 2019-04-29 EP EP19794017.4A patent/EP3784244A1/en not_active Withdrawn
- 2019-04-29 BR BR112020021977-0A patent/BR112020021977A2/pt not_active IP Right Cessation
- 2019-04-29 JP JP2021509727A patent/JP2021522341A/ja active Pending
- 2019-04-29 AU AU2019260835A patent/AU2019260835A1/en not_active Abandoned
- 2019-04-29 CA CA3098603A patent/CA3098603A1/en not_active Abandoned
- 2019-04-29 KR KR1020207033364A patent/KR20210015795A/ko unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20210371385A1 (en) | 2021-12-02 |
| EP3784244A1 (en) | 2021-03-03 |
| JP2021522341A (ja) | 2021-08-30 |
| WO2019210327A1 (en) | 2019-10-31 |
| KR20210015795A (ko) | 2021-02-10 |
| MX2020011376A (es) | 2021-02-09 |
| BR112020021977A2 (pt) | 2021-01-26 |
| CA3098603A1 (en) | 2019-10-31 |
| CN112384221A (zh) | 2021-02-19 |
| AU2019260835A1 (en) | 2020-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1259232A1 (zh) | Menin-mll的取代抑制劑及其使用方法 | |
| IL280709A (en) | Converted indoles and methods of using them | |
| IL266093A (en) | Oxysterols and methods of using them | |
| ZA201905677B (en) | Glycan-interacting compounds and methods of use | |
| IL266092A (en) | Oxysterols and methods of using them | |
| IL267291A (en) | Actonucleotidase inhibitors and methods of using them | |
| IL279475A (en) | Actonucleotidase inhibitors and methods of using them | |
| PT3481846T (pt) | 24-hidroxiesteroides 11-substituídos para utilização no tratamento de afeções relacionadas com nmda | |
| LT3436022T (lt) | Oksisteroliai ir jų panaudojimo būdai | |
| IL274504A (en) | 2ACSS inhibitors and methods of their use | |
| IL283387A (en) | Diarylhydantoin compounds and methods of use thereof | |
| IL289748A (en) | Heterodimers and methods of using them | |
| IL277963A (en) | Bicyclic carboxamides and methods of using them | |
| IL283782A (en) | Analosomes and methods of use | |
| IL281420A (en) | Deuterium enriched pirfenidone and methods of using it | |
| GB2562984B (en) | Hydrate inhibitors and methods of use | |
| GB201600263D0 (en) | Fixation device and method of manufacture and use | |
| EP3849664C0 (en) | PHENOXY-PYRIDYL-PYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF | |
| IL276053A (en) | Therapeutic Gard and methods of its use | |
| GB201810679D0 (en) | Seall apparatus and methods of use | |
| EP3363841C0 (de) | Verfahren und vorrichtung zur direktkristallisation von polykondensaten | |
| ZA201908276B (en) | Charge-tagged nucleotides and methods of use thereof | |
| GB202009064D0 (en) | Compounds and methods of use | |
| SG11202010583VA (en) | Polymorphic and amorphous forms of isoquinolinone and methods of use thereof | |
| EP3849663C0 (en) | PYRIMIDINYL-HETEROARYLOXY-NAPHTHYL COMPOUNDS AND METHODS OF USE |